TrialSignal
Clinical trial intelligence report
Handheld Ultrasound-guided Cannulation of Difficult Haemodialysis Arteriovenous Access by Renal Nurses - A Randomised Controlled Trial
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT05410691
Status
COMPLETED
Phase
NA
Sponsor
National Healthcare Group, Singapore
Executive brief
Investment-Ready Snapshot
This completed randomized controlled trial evaluated the effectiveness of handheld ultrasound (US) guidance for cannulation of difficult arteriovenous fistulas (AVF) or grafts (AVG) by renal nurses. The study aimed to improve cannulation success rates and reduce complications associated with vascular access in hemodialysis patients.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT05410691
Indication
Hemodialysis Complication
Modality
medical device
Target
Difficult arteriovenous access in hemodialysis patients
Intervention
Handheld US device
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.